Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter

Purpose This study evaluated the accuracy of attenuation imaging (ATI) for the assessment of hepatic steatosis in pediatric patients, in comparison with the FibroScan vibration-controlled transient elastography controlled attenuation parameter (CAP). Methods Consecutive pediatric patients referred f...

Full description

Bibliographic Details
Main Authors:	Pyeong Hwa Kim, Young Ah Cho, Hee Mang Yoon, Boram Bak, Jin Seong Lee, Ah Young Jung, Seak Hee Oh, Kyung Mo Kim
Format:	Article
Language:	English
Published:	Korean Society of Ultrasound in Medicine 2022-10-01
Series:	Ultrasonography
Subjects:	pediatrics obesity fatty liver nonalcoholic fatty liver disease ultrasonography
Online Access:	http://www.e-ultrasonography.org/upload/usg-21246.pdf

Similar Items

Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2022-04-01)

How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
by: Duck Min Seo, et al.
Published: (2023-04-01)

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
by: Sun Kyung Jeon, et al.
Published: (2021-01-01)

Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis: a systematic review and meta-analysis of prospective studies
by: Jong Keon Jang, et al.
Published: (2022-01-01)

Noninvasive assessment of hepatic steatosis using a pathologic reference standard: comparison of CT, MRI, and US-based techniques
by: Jae Seok Bae, et al.
Published: (2022-04-01)

Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis
by: Jeongin Yoo, et al.
Published: (2020-04-01)

US Attenuation Imaging for the Evaluation and Diagnosis of Fatty Liver Disease
by: Seung Jun Lee, et al.
Published: (2023-05-01)

Ultrasound-Guided Attenuation Parameter May Replace B-mode Ultrasound in Diagnosing Nonalcoholic Fatty Liver Disease
by: Bo Jiang, MD, Yiman Du, MD, Xiang Fei, MD, Jianing Zhu, MD, Lianhua Zhu, MD, Qiuyang Li, MD, Yukun Luo, MD, PhD
Published: (2023-09-01)

Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
by: Jeong-Ju Yoo, et al.
Published: (2020-11-01)

Correlational study of nonalcoholic fatty liver disease diagnosed by ultrasonography with lipid profile and body mass index in adult nepalese population
by: Umesh P Khanal, et al.
Published: (2019-01-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
by: Jinwang Li, et al.
Published: (2021-12-01)

Modifications decrease hepatic steatosis in Taiwanese with metabolic‐associated fatty liver disease
by: Tso‐Tsai Liu, et al.
Published: (2022-10-01)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
by: Yun Bin Lee, et al.
Published: (2019-03-01)

The association of hepatic steatosis and fibrosis with heart failure and mortality
by: Jiyun Park, et al.
Published: (2021-09-01)

Diagnostic accuracy of CT and Doppler US for hepatic outflow obstruction after pediatric liver transplantation using left lobe or left lateral section grafts
by: Pyeong Hwa Kim, et al.
Published: (2024-03-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

Hepatic enzyme concentrations as indicators of nonalcoholic fatty liver disease
by: Alvina Alvina
Published: (2016-02-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
by: Sang Jun Yoon, et al.
Published: (2023-03-01)

Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
by: Jung Wook Seo, et al.
Published: (2023-07-01)

Influence of pancreatic steatosis severity on the course of pediatric nonalcoholic fatty pancreas disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Examining genetic associations with hepatic steatosis in Mexican-origin adults
by: Mario Jesus Trejo, et al.
Published: (2023-09-01)

Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Eun Jeoung Lee, et al.
Published: (2024-03-01)

Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH)
by: Hitoshi Maruyama, et al.
Published: (2020-01-01)

Dietary Alaska pollock protein attenuates liver steatosis and alters gut microbiota in leptin-deficient ob/ob mice
by: Hayato Maeda, et al.
Published: (2020-12-01)

Honokiol Improves Liver Steatosis in Ovariectomized Mice
by: Yeon-Hui Jeong, et al.
Published: (2018-01-01)

The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students
by: Robert Nastasa, et al.
Published: (2021-12-01)

Hyperechoic pancreas on ultrasonography: an analysis of its severity and clinical implications
by: Hyunji Oh, et al.
Published: (2022-04-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study
by: Gi-Ae Kim, et al.
Published: (2023-12-01)

Predictors of nonalcoholic fatty liver disease among middle-aged Iranians
by: Reza Etminani, et al.
Published: (2020-01-01)

Severity of hyperechoic pancreas on ultrasonography as a risk factor for glycemic progression
by: Jiyun Oh, et al.
Published: (2021-10-01)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
by: Ulasoglu C, et al.
Published: (2021-06-01)

Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults
by: Jeong-Ju Yoo, et al.
Published: (2022-02-01)

Multiple MicroRNAs Ameliorate Hepatocyte Steatosis and Injury by Suppressing FABP1 Expression
by: Yun-li Wu, et al.
Published: (2017-12-01)

Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study
by: Yu-ling Chen, et al.
Published: (2021-05-01)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
by: Young Seok Kim, et al.
Published: (2013-06-01)

Genetic determinants of hepatic steatosis in man
by: Amanda J. Hooper, et al.
Published: (2011-04-01)

Value of screening for nonalcoholic fatty liver disease in hyperuricemic patients with normal body mass index by two-dimensional ultrasound: Upper Egypt experience
by: Amro M Hassan, et al.
Published: (2020-01-01)